CDC Hits Pause On Johnson &Johnson Vaccine

Image of a vaccine shot

The Centers for Disease Control and Prevention hit the pause button for injections of the Johnson & Johnson coronavirus vaccine after 6 women developed a rare blood clotting disease.

From the New York Times:

All six were women between the ages of 18 and 48 and all developed the illness within one to three weeks of vaccination. One woman died and a second woman in Nebraska has been hospitalized in critical condition.

As of Monday, nearly seven million people in the United States have received Johnson & Johnson shots so far without any other serious adverse reactions reported, and roughly nine million more doses have been shipped out to the states, according to data from the Centers for Disease Control and Prevention.

At this point, there’s no hard evidence there’s a connection between the blood clotting and the J&J vaccine.

With 6 patients out of nearly 7 million vaccinated with the vaccine, experts point out the odds of getting COVID-19 are far greater.

But, the development is sure to cause even more vaccine hesitancy in those who were already unsure about getting vaccinated.

There are no reports that the Pfizer or Moderna vaccines – which are based on a different scientific approach – have been connected to similar blood clotting.